Proposal ranks 1st out of 300 in Eurostars application
The grant proposal written by Catalyze for the Epithydia project ranked 1st out of 300 applications.
The consortium, consisting of Platomics, an infrastructure provider for the life sciences, the Belgian SME Diagenode and the Austrian Instititute of Technology, will develop an innovative epigenetic-based diagnostic kit for the detection of thyroid cancer. The kit will be based on a promising set of DNA methylation markers. In this project, these biomarkers will be developed into an actual IVD kit that will be analytically and technically validated, and subsequently tested in a proof-of principle study. Directly after this project, the consortium will perform larger scale validation studies.